华领医药-B（02552.HK）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

公众及其他64.80%
风投/私募28.14%
个人与内部人士5.58%
机构投资者1.48%

主要股东

主要股东最新
股东
Arch Venture Partners, L.P.	12.55%	1.25 亿	0.00%	+0	2025/12/31
VR Management, LLC	10.38%	1.03 亿	0.00%	+0	2025/12/31
WuXi PharmaTech Healthcare Fund I General Partner L.P.	5.20%	5,180.76 万	0.00%	+0	2025/06/19
Li ChenFounder, CEO, Member of Portfolio Advisory Board & Executive Director	4.07%	4,053.87 万	0.08%	+75.00 万	2026/07/15
Chien Cheng LinExecutive VP, Chief Strategy Officer & Executive Director	0.85%	849.93 万	0.00%	+0	2025/12/31
Yi ZhangSenior VP of Pharma Development, Chief Medical Officer – China and Executive Director	0.64%	637.50 万	0.00%	+0	2025/12/31
JP Morgan Asset Management	0.53%	524.40 万	0.00%	+0	2025/12/31
E Fund Management Co., Ltd.	0.40%	398.52 万	0.00%	+0	2025/06/30
State Street Investment Management	0.24%	240.85 万	<0.01%	-8,500.00	2026/08/31
Dimensional Fund Advisors LP	0.17%	170.24 万	<0.01%	+7.25 万	2026/08/31
American Century Investment Management Inc	0.11%	110.10 万	0.04%	+40.30 万	2026/07/31
China Universal Asset Management Company Ltd.	0.03%	31.35 万	0.00%	+0	2025/12/31
Robert Taylor NelsenNon-Executive Chairman	0.02%	15.00 万	0.00%	+0	2025/12/31
Yiu Wa TsuiIndependent Non-Executive Director	<0.01%	2.40 万	0.00%	+0	2025/12/31
Connor, Clark & Lunn Investment Management Ltd.	<0.01%	1.20 万	0.00%	+0	2025/12/31
First Trust Advisors LP	0.00%	0.00	0.36%	-358.03 万	2026/06/30